(Abst.) Teriflunomide safety and efficacy in advanced progressive MS on: January 01, 2021, 03:26:12 pm #1 From PubMed (January 1, 2021), "Teriflunomide safety and efficacy in advanced progressive multiple sclerosis": Teriflunomide Safety and Efficacy in Advanced Progressive Multiple Sclerosis - PubMed In an advanced progressive multiple sclerosis population, no substantial differences in tolerability, safety, sustained EDSS progression, or sustained T25FW worsening over time were observed betwee... PubMed · pubmed.ncbi.nlm.nih.gov Logged MS Speaks--online for 20 yearsSPMS, diagnosed 1980. Avonex 2001-2004. Copaxone 2007-2010. Glatopa (glatiramer acetate 40mg 3 times/week) 12/16/20 - 3/16/24.
